Vandetanib 300mg

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Unresectable Locally Advanced or Metastatic, Medullary Thyroid Carcinoma

Drug Information

Target Indication

Unresectable Locally Advanced or Metastatic, Medullary Thyroid Carcinoma

Clinical Trial

Last updated: 12/12/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

SNY

Sanofi

Related Pipeline

Influenza (Healthy Volunteers)

Type 2 Diabetes Mellitus

Diphtheria

Non Small Cell Lung Cancer

Influenza